Martin Shkreli's legacy: Putting a 'fine point' on the drug pricing debate By: CNBC.com News March 09, 2018 at 07:57 AM EST Martin Shkreli's actions involving pharmaceutical pricing have had a long-lasting impact. Read More >> Related Stocks: Acorda Therapeutics Express Scripts Holding Mylan Sage Therapeutic Com
